Hyponatremia and long-term outcomes in chronic heart failure--an observational study from the Duke Databank for

Luca Bettari1, Mona Fiuzat, Linda K Shaw

  • 1Section of Cardiovascular Diseases, Department of Experimental and Applied Medicine, University of Brescia, Brescia, Italy. luca_bettari@yahoo.it

Journal of Cardiac Failure
|December 27, 2011
PubMed

Insights

Hyponatremia, or low sodium levels, is common in heart failure (HF) patients with systolic dysfunction. This condition independently predicts a higher risk of death and cardiovascular events, impacting long-term survival.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Background:

  • Hyponatremia is a known short-term outcome predictor in heart failure (HF).
  • Its long-term prognostic value in HF patients with systolic dysfunction remains unclear.

Purpose of the Study:

  • To investigate hyponatremia as an independent predictor of long-term mortality and cardiovascular events in HF patients with systolic dysfunction.

Main Methods:

  • A cohort of 1,045 HF patients with systolic dysfunction was identified from the Duke Databank for Cardiovascular Diseases.
  • Multivariable Cox proportional regression models were used to assess the association between hyponatremia and outcomes.

Main Results:

  • Hyponatremia was present in 10.2% of patients and associated with older age, anemia, and more severe HF.
  • Unadjusted analysis showed hyponatremia increased risk of all-cause death (HR 1.89) and CV death/rehospitalization (HR 1.40).
  • Multivariable analysis confirmed hyponatremia as an independent predictor for all-cause death (HR 1.42) and CV death/rehospitalization (HR 1.45).

Conclusions:

  • Hyponatremia is prevalent in HF patients with left ventricular (LV) dysfunction.
  • Low sodium levels are independently linked to increased all-cause mortality and cardiovascular mortality/rehospitalization.
Abstract

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...